患者特异性TBX5-G125R变异导致转录深度失调与心房功能障碍
研究分析Holt-Oram综合征家系心电图,并将TBX5-p.G125R引入小鼠基因组,进行电生理、转录组和表观遗传分析。患者高频出现房性早搏和房室传导障碍;小鼠形态正常但出现R-R间期多变、房性早搏和房颤易感性,心房心肌细胞转录变化最显著,表观遗传揭示数千个TBX5-p.G125R敏感调控元件。
要点
- TBX5-p.G125R患者表现房性早搏和房室传导障碍高发。
- Tbx5G125R/+小鼠形态正常但出现房性早搏和房颤易感。
- 心房心肌细胞转录变化最显著,涉及超千个编码和非编码转录本。
核心结论
- TBX5致病错义变异在体内诱导心房转录调控网络和表观遗传状态的深刻变化,导致类似人类变异携带者的心律失常。
研究设计与样本
- 分析一个扩展Holt-Oram综合征家系的心电图,并将TBX5-p.G125R变异引入小鼠基因组(Tbx5G125R)。
- 进行电生理分析(心电图、光学标测、膜片钳、细胞内钙测量)、转录组学(单核和组织RNA测序)和表观遗传分析(ATAC-seq、H3K27ac CUT&RUN)。
主要发现
- Holt-Oram综合征患者房性早搏和房室传导障碍发生率高。
- Tbx5G125R/+小鼠形态未受影响,但显示R-R间期多变、房性早搏和房颤易感性。
- 心房传导速度未受影响,但分离的心肌细胞收缩和舒张期细胞内钙浓度降低、动作电位延长。
- 心房转录谱显示心肌细胞转录变化最显著,鉴定出超过一千个差异表达的编码和非编码转录本。
- 表观遗传分析揭示数千个TBX5-p.G125R敏感的推定调控元件(包括增强子)在心房心肌细胞中获得可及性。
关键数值与推荐
- 大多数可及性增加的位点被Tbx5占据;可及性降低的少数位点富集SP和KLF家族转录因子的DNA结合基序。
临床怎么用
- TBX5-p.G125R变异携带者应关注房性早搏和房室传导障碍,小鼠模型可用于研究心房颤动机理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The pathogenic missense variant p.G125R in TBX5 (T-box transcription factor 5) causes Holt-Oram syndrome (also known as hand-heart syndrome) and early onset of atrial fibrillation. Revealing how an altered key developmental transcription factor modulates cardiac physiology in vivo will provide unique insights into the mechanisms underlying atrial fibrillation in these patients. METHODS: We analyzed ECGs of an extended family pedigree of Holt-Oram syndrome patients. Next, we introduced the TBX5-p.G125R variant in the mouse genome (Tbx5G125R) and performed electrophysiologic analyses (ECG, optical mapping, patch clamp, intracellular calcium measurements), transcriptomics (single-nuclei and tissue RNA sequencing), and epigenetic profiling (assay for transposase-accessible chromatin using sequencing, H3K27ac [histone H3 lysine 27 acetylation] CUT&RUN [cleavage under targets and release under nuclease sequencing]). RESULTS: We discovered high incidence of atrial extra systoles and atrioventricular conduction disturbances in Holt-Oram syndrome patients. Tbx5G125R/+ mice were morphologically unaffected and displayed variable RR intervals, atrial extra systoles, and susceptibility to atrial fibrillation, reminiscent of TBX5-p.G125R patients. Atrial conduction velocity was not affected but systolic and diastolic intracellular calcium concentrations were decreased and action potentials were prolonged in isolated cardiomyocytes of Tbx5G125R/+ mice compared with controls. Transcriptional profiling of atria revealed the most profound transcriptional changes in cardiomyocytes versus other cell types, and identified over a thousand coding and noncoding transcripts that were differentially expressed. Epigenetic profiling uncovered thousands of TBX5-p.G125R-sensitive, putative regulatory elements (including enhancers) that gained accessibility in atrial cardiomyocytes. The majority of sites with increased accessibility were occupied by Tbx5. The small group of sites with reduced accessibility was enriched for DNA-binding motifs of members of the SP (specificity protein) and KLF (Krüppel-like factor) families of transcription factors. These data show that Tbx5-p.G125R induces changes in regulatory element activity, alters transcriptional regulation, and changes cardiomyocyte behavior, possibly caused by altered DNA binding and cooperativity properties. CONCLUSIONS: Our data reveal that a disease-causing missense variant in TBX5 induces profound changes in the atrial transcriptional regulatory network and epigenetic state in vivo, leading to arrhythmia reminiscent of those seen in human TBX5-p.G125R variant carriers.
引用
- van Ouwerkerk AF, Bosada FM, van Duijvenboden K, et al. Patient-Specific TBX5-G125R Variant Induces Profound Transcriptional Deregulation and Atrial Dysfunction. Circulation. 2022. PMID: 35113653. doi:10.1161/CIRCULATIONAHA.121.054347
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。